tiprankstipranks
Trending News
More News >

Jane A Gross Insider Profile

11 Followers
Jane A Gross, SVP & Chief Scientific Officer at Aptevo Therapeutics, holds 9.75K shares in aTyr Pharma (Ticker: ATYR), holds 109.58K shares in Aptevo Therapeutics (Ticker: APVO). Most recently, Jane A Gross Bought ― shares of aTyr Pharma on Mar 17, 2025 for an estimated value of 15.00K.
tipranks
Jane A Gross

Jane A Gross
Aptevo Therapeutics (APVO)
SVP & Chief Scientific Officer

Not Ranked
Jane A Gross has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$352K
86.92%
13.08%
A breakdown of Jane A Gross's holdings

Insider Roles

Aptevo Therapeutics
(APVO)
SVP & Chief Scientific Officer
aTyr Pharma
(ATYR)
Director
Roles that Jane A Gross holds in companies

Most Profitable Insider Trade

Stock:
aTyr Pharma
(ATYR)
Rating:Informative Buy
Date:Mar 17, 2025 - Today
Return:+45.30%
The most profitable trade made by Jane A Gross

Jane A Gross's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aptevo Therapeutics
Mar 04, 2019
SVP & Chief Scientific Officer
Uninformative Buy
10.09K
$305.74K
aTyr Pharma
Mar 17, 2025
Director
Informative Buy
15.00K
$46.02K
List of latest transactions for each holding click on a transaction to see Jane A Gross's performance on stock

Jane A Gross insider profile FAQ

What is the percentage of profitable transactions made by Jane A Gross?
The percentage of profitable transactions made by Jane A Gross is ―.
    What is the average return per transaction made by Jane A Gross?
    The average return per transaction made by Jane A Gross is ―.
      What stocks does Jane A Gross hold?
      Jane A Gross holds: APVO, ATYR stocks.
        What was Jane A Gross’s latest transaction?
        Jane A Gross latest transaction was an Informative Buy of $15.00K.
          What was Jane A Gross's most profitable transaction?
          Jane A Gross’s most profitable transaction was an Informative Buy of ATYR stock on March 17, 2025. The return on the trade was 45.30%.
            What is Jane A Gross's role in Aptevo Therapeutics?
            Jane A Gross's role in Aptevo Therapeutics is SVP & Chief Scientific Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.